戻る Agenda
Session 5: Track B: Responsible On-Boarding of Precision Medicine: Why Bytes and Spit Aren’t Enough
Session Chair(s)
Andrew Atkinson
Manager, Emerging Sciences Policy
Health Canada, Canada
Scientific advances are expanding the potential for personalized medicine to improve healthcare for Canadians. Equally, these developments could draw resources away from critical care in other healthcare sectors. In this session, the responsible introduction of personalized medicine will be explored including opportunities for cost savings, as well as mitigating the economic impacts of high cost treatments.
Speaker(s)
Health Technology Assessment for Reimbursement of Emerging Precision Medicine Technologies
Wendy Ungar, PhD, MSc
The Hospital for Sick Children Research Institute, Canada
Senior Scientist
Personalized Healthcare: Unlocking the Data – Are We Ready?
Michael Duong
Hoffmann-La Roche Limited, Canada
Director, Evidence Generation, Medical Affairs
Rated P/G: The Importance of Phenotype in a World of Genomic Data
Kathleen Hodgkinson
Memorial University, Canada
Associate Professor of Medicine